Reilly Financial Advisors’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1
| Closed | -$1K | – | 1027 |
|
|
2021
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 987 |
|
|
2020
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 852 |
|
|
2020
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 796 |
|
|
2020
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 849 |
|
|
2020
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 835 |
|
|
2019
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 844 |
|
|
2019
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 855 |
|
|
2019
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 863 |
|
|
2019
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 881 |
|
|
2018
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 852 |
|
|
2018
Q3 | $3K | Hold |
1
| – | – | ﹤0.01% | 897 |
|
|
2018
Q2 | $3K | Hold |
1
| – | – | ﹤0.01% | 880 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 922 |
|
|
2017
Q4 | $2K | Hold |
1
| – | – | ﹤0.01% | 878 |
|
|
2017
Q3 | $2K | Hold |
1
| – | – | ﹤0.01% | 889 |
|
|
2017
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 869 |
|
|
2017
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 877 |
|
|
2016
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 796 |
|
|
2016
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 793 |
|
|
2016
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 760 |
|
|
2016
Q1 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 859 |
|